Elucidating the Internal Structure of CART-RNA Nanoparticle Assemblies for mRNA Delivery

Study Background and Research Question

The efficient delivery of messenger RNA (mRNA) into target cells remains a fundamental challenge in gene therapy and vaccine development. While lipid nanoparticles (LNPs) have become the predominant nonviral delivery system for oligonucleotides, limitations such as component complexity, stability, and immunogenicity drive the search for alternative carriers. Amphiphilic synthetic polymers, particularly Charge-Altering Releasable Transporters (CARTs), offer a modular platform for RNA delivery. However, the physicochemical principles governing their self-assembly with RNA and the resultant nanoparticle morphologies have been poorly described. The central research question addressed in this reference study is: How do variations in CART polymer composition and RNA cargo type influence the nanoscale structure and assembly of CART-RNA complexes?

Key Innovation from the Reference Study

The study introduces a systematic structural analysis of single-component, amphiphilic CART polymers complexed with RNA. Using a comprehensive suite of advanced imaging and scattering techniques, the authors demonstrate that low molar mass CARTs (≤10,000 g/mol) form nanoparticles with unique bicontinuous internal morphologies when complexed with RNA. This bicontinuous architecture—characterized by interpenetrating lipid and aqueous domains—is directly driven by the presence of RNA cargo, distinguishing these assemblies from traditional LNPs and polymeric aggregates. The report establishes definitive links between polymer block composition, cargo type (mRNA vs. siRNA), and the resulting nanostructure, enabling rational tailoring of polymeric RNA delivery agents.

Methods and Experimental Design Insights

To interrogate the internal structure of CART-RNA assemblies, the authors synthesized a series of CART amphiphiles with varying lipid and cationic block lengths via controlled ring-opening polymerization. Both mRNA and siRNA cargos were investigated. The self-assembled complexes were analyzed by:

• Cryogenic electron microscopy (CryoEM) and electron tomography (CryoET): Provided direct visualization of nanoscale morphology and internal domain architecture.
• Small-angle neutron scattering (SANS) and X-ray scattering (SAXS): Quantified domain spacings, structural order, and particle dimensions in solution.
• Systematic variation of polymer parameters: By tuning lipid/cationic block lengths and overall molar mass, the team isolated the effects of polymer structure on assembly morphology.

This multi-modal approach ensured robust, cross-validated structural assignments and enabled the authors to correlate observed morphologies with biophysical parameters and delivery-relevant features.

Core Findings and Why They Matter

The study’s key findings advance our understanding of polymeric RNA delivery systems in several ways:

• Low-molar-mass CARTs (<10,000 g/mol) self-assemble with RNA to form nanoparticles featuring bicontinuous, disordered internal morphologies, with domain spacings of 6–8 nm. These morphologies result from RNA-driven assembly and the amphiphilic nature of the transporters (reference study).
• Higher-molar-mass CARTs (≥28,000 g/mol) do not form bicontinuous assemblies with RNA; instead, they yield less ordered aggregates of particles 10–20 nm in diameter.
• Both the internal domain spacing and the degree of order in these assemblies are tunable through the chemical structure of the CART polymer and the type of RNA cargo (mRNA vs. siRNA).
• These structural features have direct implications for the stability, intracellular trafficking, and gene delivery efficiency of the nanoparticles. Morphology influences how the RNA is protected, released, and recognized by cellular machinery, potentially impacting translation efficiency and suppression of RNA-mediated innate immune activation.

By revealing that bicontinuous morphologies are RNA-driven and chemically controllable, the study provides a clear rationale for using structural design principles to optimize future mRNA delivery and translation efficiency assays. This fundamentally supports the rational development of next-generation, polymer-based gene delivery systems with improved performance and safety profiles.

Comparison with Existing Internal Articles

Several recent internal articles have addressed the challenges of mRNA delivery assay optimization, stability, and immune evasion, most notably by leveraging advanced reporter constructs. For example, EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Cap 1 Reporter for mRNA... discusses the significance of using Cap 1-capped, fluorescently labeled mRNA to enable robust gene regulation and function studies, improving both stability and detection. Similarly, Enhancing Cell-Based Assays with EZ Cap™ Cy5 EGFP mRNA (5-moUTP) highlights workflow reproducibility and dual-fluorescence tracking as key advantages for mRNA delivery and translation efficiency assays.

While these articles focus on practical assay improvements, the reference study complements these perspectives by providing a mechanistic and structural foundation for why certain polymeric carriers—potentially in combination with advanced mRNA reporters—could yield superior delivery outcomes. The revealed bicontinuous morphologies could facilitate more efficient release and translation of functional mRNA, as can be quantitatively assessed using dual-reporter constructs like EZ Cap™ Cy5 EGFP mRNA (5-moUTP). Thus, the paper’s findings bridge structural nanoscience with practical assay design discussed in internal resources.

Limitations and Transferability

Despite its comprehensive structural characterization, the study is limited by its focus on in vitro and physicochemical analysis. Functional delivery outcomes—such as mRNA translation rates, cytotoxicity, or immunogenicity—were not directly measured for the different morphologies. Additionally, while the paper systematically explores polymer composition and cargo type, the chemical diversity of both is inherently limited. The transferability of the bicontinuous assembly principle to other classes of delivery polymers or to in vivo contexts will require further empirical validation.

Protocol Parameters

• CART polymer synthesis: Ring-opening polymerization protocol; block lengths and lipid identities systematically varied to target desired molar masses (as described in the study).
• Nanoparticle assembly: Mixing of CARTs and RNA (mRNA or siRNA) in aqueous buffer under controlled stoichiometry and ambient temperature to induce self-assembly.
• Structural analysis: CryoEM/CryoET imaging performed at liquid nitrogen temperatures; SANS/SAXS measurements conducted in deuterated and buffered solutions to resolve internal domain spacing.
• Practical workflow suggestion: For mRNA delivery and translation efficiency assay optimization, select polymeric carriers and reporter mRNAs (e.g., Cy5-labeled mRNA with Cap 1 structure) that enable simultaneous tracking and functional readout.

Why this cross-domain matters, maturity, and limitations

Bridging structural nanoscience with cell-based mRNA delivery assays is essential for translating material innovations into therapeutic and research outcomes. The ability to directly visualize and tune the internal morphology of delivery nanoparticles may help address longstanding challenges in gene regulation and function studies, such as efficient cytosolic release and suppression of RNA-mediated innate immune activation. However, the maturity of this cross-domain application is still emerging, as clinical translation will require additional functional, safety, and immunogenicity studies beyond the scope of current structural reports.

Research Support Resources

To facilitate quantitative and mechanistic studies of mRNA delivery strategies inspired by this work, researchers can employ dual-fluorescence reporter constructs such as EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011). This reagent incorporates a Cap 1 structure and Cy5 label, supporting direct visualization of mRNA uptake and translation, and is compatible with the workflow requirements described for advanced gene delivery studies. When used in combination with rationally designed carriers—like those characterized in the reference study—such tools enable robust, quantitative assessment of nanoparticle-mediated mRNA delivery and intracellular trafficking.